Sponsor:
UI Contact:
Updated Date:
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices, program announcements, and requests for applications:
General Notices
- Notice of NIBIB's Participation in PA-20-135 "Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)"
National Institute of Biomedical Imaging and Bioengineering
- Guidance for NIH-funded Clinical Trials and Human Subjects Studies Affected by COVID-19
National Institutes of Health
- Flexibilities for Assured Institutions for Activities of Institutional Animal Care and Use Committees (IACUCs) Due to COVID-19
National Institutes of Health
- Notice of Information: Leveraging STRIDES for Cloud Computing Activities in Common Fund Awards
Office of Strategic Coordination (Common Fund)
- Request for Information: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Strategic Plan
National Institute of Diabetes and Digestive and Kidney Diseases
Notice of Changes to Funding Opportunities
- Notice to Extend the Expiration Date for PAR-17-214 "Limited Competition: Analysis of Data from NIA's Alzheimer's Disease Sequencing Project Follow-Up Study (U01)"
National Institute on Aging
- Notice of Clarification of Additional Considerations listed in NIAID RFA-AI-20-009, Three-Dimensional (3D) Human Biomimetics for Infectious Diseases (U19 Clinical Trial Not Allowed)
National Institute of Allergy and Infectious Diseases
- Notice of Participation of the NIAMS in PAR-19-333, SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, R44) Clinical Trial Not Allowed.
National Institute of Arthritis and Musculoskeletal and Skin Diseases
- Notice to Extend the Submission Period to the National Cancer Institute (NCI) for PA-18-592, Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed)
National Cancer Institute
- Notice of correction to PAR-19-370 NIDCR Small Grant Program for New Investigators (R03 Clinical Trial Not Allowed)
National Institute of Dental and Craniofacial Research
- Notice of NIDCR Participation in PAR-19-343 "Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 - Independent Clinical Trial Not Allowed)"
National Institute of Dental and Craniofacial Research
- Notice of Change to Cover Letter Instructions for RFA-DK-20-502, Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) Biostatistics Research Center (BRC) (Collaborative U01 Clinical Trial Required)
National Institute of Diabetes and Digestive and Kidney Diseases
- Notice of Expiration of RFA-HL-20-014 "Rare Disease Cohorts in Heart, Lung, Blood and Sleep Disorders (UG3/UH3 Clinical Trial Not Allowed)"
National Heart, Lung, and Blood Institute
- Notice of Change to Award Budget for PHS 2019-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Grant Applications
National Institutes of Health
Notices of Intent to Publish
- Notice of Intent to Publish a Funding Opportunity Announcement for NIDA Avant-Garde Award Program for HIV/AIDS and Drug Use Research (DP1, Clinical Trial Optional)
National Institute on Drug Abuse
- Notice of Intent to Publish a Funding Opportunity Announcement for Avenir Award Program for Research on Substance Use Disorders and HIV/AIDS (DP2 Clinical Trial Optional)
National Institute on Drug Abuse
Notices of Special Interest
- Notice of Special Interest: Administrative Supplement Opportunity to Stimulate or Strengthen Global Cancer Health Disparities Research
National Cancer Institute
- Notice of Special Interest: Alcohol and Cancer Control
National Cancer Institute
- Notice of Special Interest (NOSI): Availability of Administrative Supplements for Research in Geographically Underserved Areas
National Cancer Institute
- Notice of Special Interest (NOSI): Administrative Supplements for Development of Risk-Stratified Cancer Survivorship Care Algorithms
National Cancer Institute
- Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus
National Institute on Drug Abuse
- Notice of Special Interest (NOSI): Availability of Administrative Supplements for Providing Research Experiences in Genomic Research for Genetic Counselors
National Human Genome Research Institute
- Notice of Special Interest (NOSI): Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19)
National Heart, Lung, and Blood Institute
- Notice of Special Interest (NOSI): Administrative Supplements for Minor Alterations or Renovations to Advance Ongoing HIV/AIDS Research Projects funded by the Research Centers in Minority Institutions (RCMI) Program
National Institute on Minority Health and Health Disparities
- Notice of Special Interest to Highlight High Priority Opportunities for Intervention Development Research in Geriatric Mental Health
National Institute of Mental Health
- Notice of Special Interest (NOSI): Competitive Revisions for Firearms Injury and Mortality Prevention Research
Office of Behavioral and Social Sciences Research
National Center for Complementary and Integrative Health
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Mental Health
National Institute on Minority Health and Health Disparities
Office of Disease Prevention
Office of Research on Women's Health
Funding Opportunities
- Formative and Pilot Intervention Research for Prevention and Treatment of HIV/AIDS (R34 Clinical Trial Optional)
National Institute of Mental Health - Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32)
(PA-20-142)
National Institutes of Health
National Center for Complementary and Integrative Health
National Cancer Institute
National Eye Institute
National Human Genome Research Institute
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Environmental Health Sciences
National Institute of General Medical Sciences
National Institute of Mental Health
National Institute of Nursing Research
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
- Center of Excellence for Research on Complementary and Integrative Health (P01,Clinical Trial Optional)
National Center for Complementary and Integrative Health
- Catalytic Tool and Technology Development in Kidney, Urologic, and Hematologic Diseases (R21 Clinical Trial Not Allowed)
National Institute of Diabetes and Digestive and Kidney Diseases - Firearm Injury and Mortality Prevention Research (R61 Clinical Trial Optional)
Office of Behavioral and Social Sciences Research
National Center for Complementary and Integrative Health
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Minority Health and Health Disparities
Office of Disease Prevention
Office of Research on Women's Health - Research to Reduce Morbidity and Improve Care for Pediatric, and Adolescent and Young Adult (AYA) Cancer Survivors (R01 Clinical Trial Optional)
- Research to Reduce Morbidity and Improve Care for Pediatric, and Adolescent and Young Adult (AYA) Cancer Survivors (R21 Clinical Trial Optional)
National Cancer Institute - Patient-oriented Research to Mitigate Health Disparities and Lessen the Burden of Chronic Diseases Within the Mission of NIDDK (R01 Clinical Trial Optional)
National Institute of Diabetes and Digestive and Kidney Diseases
- Genomic Predictors of Pregnancy Loss (R01 Clinical Trial Not Allowed)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Human Genome Research Institute
- Novel Synthetic Nucleic Acid Technology Development (R01 Clinical Trial not allowed)
- Novel Synthetic Nucleic Acid Technology Development (R21 Clinical Trial not allowed)
National Human Genome Research Institute
- Novel Synthetic Nucleic Acid Technology Development (R43/R44)( Clinical Trial not allowed)
National Human Genome Research Institute
National Center for Advancing Translational Sciences
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at dsp@uiowa.edu (link sends e-mail) or 335-2123, or email Carrie Damon at carolyn-damon@uiowa.edu (link sends e-mail) or Dave Myers at dave-myers@uiowa.edu (link sends e-mail) or Lynn Hudachek at lynn-hudachek @uiowa.edu (link sends e-mail)